Noah Goodman, MBA

Chief Business Officer

Noah Goodman is the Chief Business Officer at Kymera Therapeutics. Before joining Kymera, Noah held senior leadership roles at Chroma Medicine and nChroma Bio, serving as President and Chief Business Officer through the merger with Nvelop Therapeutics. He also served as Executive Director and Head of Business Development at Cadent Therapeutics, which was subsequently acquired by Novartis, and Seres Therapeutics, where he was responsible for leading collaborations and licensing transactions across several therapeutic areas. Earlier in his career, Noah also worked in business development at Spark Therapeutics and served as a management consultant at Easton Associates, a boutique life sciences consultancy. He holds a B.S. in neuroscience from the University of Michigan and an M.B.A. from the Wharton School of the University of Pennsylvania.